💥Join UPSC 2027,2028 Mentorship (August Batch) + XFactor Notes & Microthemes PDF
Talk to Mentor

Civilsdaily

Login

Distribution: weekly

  • Undermining vaccination for all

    The article highlights the issues with the new vaccine strategy adopted by the government.

    Revamped vaccine strategy

    • With the second Covid-19 wave reaching catastrophic proportions, the Government of India has acted by unveiling a completely revamped vaccine strategy.
    • Two key elements are the hallmark of this new strategy, which will be implemented from May 1.
    • First, the vaccination drive has now been extended to the entire adult population, namely, to those above 18 years.
    • Second, vaccine manufacturers have been given the freedom to sell 50% of their vaccine production to State governments and private hospitals.
    •  A third element of the vaccine strategy, which was not announced formally, is a grant of ₹45 billion to the two vaccine manufacturers, the Serum Institute of India (SII) and Bharat Biotech, to boost their capacities.

    Issues with the new vaccine strategy

    1) Control over the market for vaccine

    • The central government has given up its control over the market for vaccines, a key feature of the vaccine roll-out plans thus far.
    • This issue assumes further significance since the Government of India is well aware about the significance of vaccinating every citizen in the country; “none of us will be safe until everyone is safe”.
    •  It is, therefore, vitally important that public health authorities in the country take an objective view of the realities of the country before adopting strategies for vaccine availability.

    2) Vaccine export

    • The phased roll-out of the government’s ambitious vaccination drive, beginning with health-care and frontline workers in January was in sync with the availability of vaccines in the country.
    •  But, given that India too saw a degree of “vaccine-scepticism”, the Government of India found itself in a situation where it could promise exports of vaccines to 95 countries, mostly in Africa and Asia.
    • As of April 26, these countries have received more than 66.4 million doses of vaccines from India.
    • Until now, nearly 142 million vaccine doses have been administered in the country, the third highest in the world.
    • However, in terms of population share, less than 2% has received both vaccine doses, while less than 9% has received one dose.
    • But there is one worrying facet, which is that a demand-supply mismatch has begun to appear as the coverage of the vaccine-eligible population expanded.
    • The largest supplier, SII, gave two explanations for its inability to meet its commitments.
    • The first was that the United States Government had restricted exports of vaccine culture and other essential materials.
    • Second, the company complained that it lacked the financial capacity to expand its production, requesting a grant of ₹30 billion from the government.

    3) Onus on the States

    • Central government have allowed vaccine producers to sell 50% of their production directly to State governments and private hospitals.
    • The central government would continue to support vaccination for people above 45 years, and health-care workers and frontline workers.
    • The new strategy shifts the onus onto the State governments, which have to take decisions regarding free vaccination for people above 18 years.
    • The government has not fixed the vaccine prices and has allowed the producers to pre-declare the prices they would charge from the State governments and private hospitals, a sharp departure from the extant strategy.
    • New policy fragments the market into three layers namely, central government procurement, State government procurement and the private hospitals.
    • This layering of the market would allow the producers to charge high prices from the State governments and private hospitals.
    • The new strategy would shift the burden of vaccination of the young population, namely, those between 18-44 years, entirely on the State governments.
    •  This implies that the vaccination of a significant section of the population depends on the financial health of each State government, resulting in inequitable access to vaccines across States. 

    4) Public money given for expanding production capacity

    • In view of the advance of ₹45 billion made by the Government of India to the two vaccine producers in India for expanding their production capacities decision to deregulate the vaccine market raises serious questions.
    • This question is more pertinent in India, where access to affordable vaccines is critical for ensuring “vaccination for all”.

    Way forward

    •  Rather than allowing duopoly in the vaccine market, the government should have ensured a competitive market for vaccines.
    • One positive step that the government has taken in this direction is to increase production of Bharat Biotech’s vaccine through the involvement of three public sector undertakings, including Haffkine Institute.
    • There is a need for more open licensing of this vaccine to scale up production.

    Conclusion

    There can be no alternative to vaccination for all if we want to overcome the Covid and to ensure that government needs to rethink its new strategy.

  • India third highest military spender in 2020: SIPRI

    What the SIPRI database says

    • India was the third largest military spender in the world in 2020, behind only the US and China.
    • The US accounted for 39 per cent of the money spent on military globally, China accounted for 13 per cent, and India accounted for 3.7 per cent of the globe’s share.
    • The US spent a total of $778 billion in 2020, China spent $252 billion and India’s military expenditure was $72.9 billion.
    • The United States’ military spending was 3.7 per cent of its GDP while the corresponding numbers for China and India were 1.7 per cent and 2.9 per cent respectively.
    • The other top spenders included Russia with $61.7 billion, the UK at $59.2 billion, Saudi Arabia at $57.5 billion, followed by Germany and France at just under $53 billion each.

    Increase in spending in the year of pandemic

    •  SIPRI said that the total “global military expenditure rose to $1981 billion last year, an increase of 2.6 per cent in real terms from 2019.
    • 2.6 per cent increase in world military spending came in a year” when the global GDP shrank by 4.4 per cent largely due to the economic impacts of the Covid-19 pandemic.
    • Military spending as a share of GDP—the military burden—reached a global average of 2.4 per cent in 2020, which is the biggest year-on-year rise in the military burden since the global financial and economic crisis in 2009.

  • Complexities of herd immunity

    What is herd immunity

    • The herd immunity concept is based on lowering the number of susceptible individuals.
    • If sufficient individuals in the population are immune either through vaccination or a prior exposure, then the number of susceptible individuals drops.
    • For example, if the immune population is 70%, then the susceptible population is 30%.

    Does herd immunity really protect from subsequent waves?

    • The number of daily cases depends on three factors: The number of infectious people in the population, the number of susceptible individuals, and the rate of transmission of the virus.
    • The rate of transmission is dependent on the nature of the virus and the extent of contact between individuals.
    • So, if the rate of transmission increases due to change in social behaviour and increased contact then even with a large percentage of the immune population, a significant number of daily cases can result.
    • The “herd immunity” number is not a static number but it changes depending on the rate of transmission of the virus and the extent of virus present.

    Estimating exposures in metro cities

    • Serosurveys indicated that Covid had touched 56% of population in Delhi by January; 75% in some slums Mumbai in November, and about 30% in Bengaluru in November.
    • The population touched by Covid can also be estimated by the Infection Fatality Rate (IFR).
    • This is the total number of deaths divided by the total people infected. In India, the estimate is 0.08%.
    • So this number can be used to back-calculate the number of infections based on the number of deaths in the different cities.
    • The table given below shows the number of people exposed to Covid in some metros until January 31 using the method above.

    What are the reasons behind the recent surge

    • The reasons behind the recent surge are not fully understood.
    • The one factor that is not in doubt, however, is that interaction and contact with the population has increased since February.
    • Such increased contact increased the virus in circulation and led to increased cases in the susceptible population.

  • Centre uses Disaster Management Act to restrict liquid oxygen use for non-medical purposes

    Order under Disaster Management Act 2015

    • Invoking the Disaster Management Act, the Centre ordered States that all liquid oxygen shall be made available to the government and will be used for medical purposes only.
    • The order said that under section 10(2)(I) and section 65 of the DM Act, States had to ensure that “liquid oxygen is not allowed for any non medical purpose”
    • The order was passed after the review of oxygen supply situation in the country.

    Dealing with the shortage

    • On April 22, Centre issued order under the DM Act, making the district magistrates and senior superintendent of police personally liable to allow unhindered inter-State movement of vehicles carrying medical oxygen.
    • Despite MHA’s orders and letters, States continued to flag shortage of oxygen supply.
    • Medical oxygen to States are being provided as per daily quota decided by an empowered group of officers in central ministries.

  • [pib] PM launches distribution of e-property cards under SWAMITVA scheme

    e-Property cards under SWAMITVA scheme

    • The Prime Minister launched the distribution of e-property cards under the SWAMITVA scheme on National Panchayati Raj Day (24 April).
    • 4.09 lakh property owners were given their e-property cards on this occasion, which also marked the rolling out of the SVAMITVA scheme for implementation across the country.
    • Under the scheme, the entire village properties are surveyed by drone and property card are distributed to the owners.
    • The Scheme has infused a new confidence in the villages  as property documents remove uncertainty and reduce the chances of property disputes while protecting the poor from exploitation and corruption.
    • This eases credit possibility also.

    About SWAMITVA Scheme

    • SVAMITVA (Survey of Villages and Mapping with Improvised Technology in Village Areas) was launched by Prime Minister on 24th April 2020.
    • It is a Central Sector Scheme to promote a socio-economically empowered and self-reliant rural India.
    • The Scheme has the potential to transform rural India using modern technical tools of mapping and surveying.
    • It paves the way for using the property as a financial asset by villagers for availing loans and other financial benefits.
    • The Scheme will cover around 6.62 Lakh villages of the entire country during 2021-2025.

  • Civil service reforms in India

    The article highlights the role bureaucracy can play in the development of the country and suggests the ways to deal with the challenges faced by the bureaucracy.

    Background of the PSU’s

    • In the 1950s and ’60s, the private sector had neither the capability to raise capital to take the country on the path of industrialisation.
    • The state had to take on the role of industrialising the country by establishing PSUs.
    • The civil services became the natural choice for establishing and managing these units.
    • They delivered substantially, if not fully.
    • Even after privatisation, the bureaucracy would be required for the transition of PSUs from the public to the private sector.

    Need for structural transformation agenda

    • The goal of making India a $5-trillion economy needs a coherent structural transformation agenda and extraordinary implementation capacity.

    1) Dealing with crony capitalisms

    • Since Independence, the political survival of Indian regimes has required pleasing a powerful land-owning class and a highly concentrated set of industrial capitalists.
    • The elites of business houses and land owners share no all-encompassing development agenda.
    • Can the present regime find a way out of this conundrum?

    2) Implementing the development agenda

    • While the agenda is an outcome of political choices, the thinking goes that market mechanisms should be used as far as possible to make economic choices.
    • This argument is at the heart of the privatisation of state assets.
    • However, markets operate well only when they are supported by other kinds of social networks, which include non-contractual elements like trust.
    • Particularly in industrial transformation, there must be an essential complementarity of state structures and market exchange.
    • Only a competent bureaucracy can provide this.
    • It is for this reason that Max Weber argued that the operation of large-scale capitalist enterprise depended upon the kind of order that only a modern bureaucratic state can provide.

    3) Removing the constraints on the bureaucracy

    • The political and permanent executives had to work as a team through mutual respect for each other’s roles as defined in the Constitution.
    • Every deviation from these ideals has lowered the capacity of the state to deliver.
    • This is the result of electoral politics where the essence of the state action is the exchange relationships between the incumbent governments and its supporters.
    • All this is achieved by undermining the impartiality of the bureaucracy in implementing rules and giving opinions frankly.
    • The power to transfer is weaponised to bring the bureaucrats to heel and it works because authority sits with the position not the person.
    • The pressure on officials to behave contrary to the ostensible purpose of the department undermines to a great extent the ability of the state to promote development.
    • If privatisation is to work, then the corruption-transfer mechanism and its effects on the bureaucracy has to go.

    4) Corporate coherence

    • Corporate coherence is the ability of the bureaucracy internally to resist the invisible hands of personal maximisation by undercutting the formal organisational structure through informal networks.
    • If this goes too far, then everything becomes open to sale and the state becomes predatory.

    Consider the question “What are the issues facing civil services in India? Suggest the ways to deal with these issues.”

    Conclusion

    We need to fight the increasing tendency to grab public resources and restore to the bureaucracy its autonomy of action as envisaged in the Constitution by de-weaponising transfers.

  • Cybersecurity norms for payment services

    What prompted RBI to take such step

    • Following a series of data breaches faced by operators including Mobikwik and payment aggregator JusPay, the Reserve Bank of India (RBI) will soon issue cybersecurity norms for payment service providers (PSPs).
    • On cyber frauds, Reserve Bank of India has issued very recently basic guidelines on cyber hygiene and cybersecurity for banks and certain NBFCs,
    • The standards for fintech-driven payment services providers will be similar to these cyber hygiene norms issued recently.
    • the critical challenge for regulators would be to speed up the absorption of fintech without undermining the financial system’s integrity or stability.

    UPI dominated by limited players

    •  There are not too many payment systems in India and the number of players is limited.
    • Two apps provide about 70% of third-party services in the UPI system.
    • The concentration of two or three third-party providers in this retail payments space could give rise to competitive weaknesses. 
    • Therefore, the National Payments Corporation of India (NPCI) had laid down a framework for a more even distribution of share of third-party app providers in the UPI system.

  • [pib] Exercise VARUNA-2021

    Details of the exercise

    • The 19th edition of the Indian and French Navy bilateral exercise ‘VARUNA-2021’ is scheduled to be conducted in the Arabian Sea from 25th to 27th April 2021.
    • The exercise will see high tempo-naval operations at sea, including advanced air defence and anti-submarine exercises, intense fixed and rotary wing flying operations, tactical manoeuvres, surface and anti-air weapon firings, underway replenishment and other maritime security operations.
    • Units of both navies will endeavour to enhance and hone their war-fighting skills to demonstrate their ability as an integrated force to promote peace, security and stability in the maritime domain.
    • On completion of exercise VARUNA-21, to consolidate accrued best practices and enhance interoperability, Indian Navy’s guided-missile frigate INS Tarkash will continue to exercise with the French Navy’s Carrier Strike Group (CSG) from 28th April to 1st May 2021.
    • During this period, the ship will take part in advanced surface, anti-submarine and air-defence operations with the French CSG.

    Significance of exercise

    • VARUNA-21 highlights growing bonhomie and showcases increased levels of synergy, coordination and inter-operability between the two friendly navies.
    • These interactions further underscore the shared values as partner navies, in ensuring freedom of seas and commitment to an open, inclusive Indo-Pacific and a rules-based international order.

  • Understanding infections after Covid-19 vaccination

    Breakthrough infections

    • There have been several cases of Covid-19 vaccinated people, even those who have received both doses, testing positive for the virus.
    • Such cases are referred to as “breakthrough” infections, indicating that the virus has been able to break through the defences created by the vaccine.
    • Such cases have led to some doubts being expressed about the effectiveness of the vaccine, and contributed to the already prevailing vaccine hesitancy. 
    • However, vaccines protect not against the infection, but against moderate or severe disease and hospitalisation.
    •  It typically takes about two weeks for the body to build immunity after being vaccinated.
    • So, the chances of a person falling sick during this period are as high — or as low — as the chances for any person who has not been vaccinated.
    •  Also, those in the priority list of vaccination, such as healthcare workers and frontline workers, have been prone to getting infected due to prolonged occupational exposure to the virus

    Full protection not possible

    • It is very well understood that no vaccine offers 100% protection from any disease.
    • However, according to the Centers for Disease Prevention and Control (CDC) in the United States, vaccinated people are much less likely to get sick, but it is never entirely ruled out.
    • Then there is the emergence of new variants of the virus.
    • Some variants of the virus are able to evade the human immune response, and therefore have a greater chance to break through the defences created through the vaccine.

    Breakthrough cases in India

    • Among 10.03 crore people who had taken only the first dose of Covishield vaccina, 17,145 had got infected.
    • That translates into a 0.02% prevalence.
    • Among the 1.57 crore people who received the second dose as well, 5,014, or about 0.03%, had got infected later.
    • About 1.1 crore doses of Covaxin have been administered until now.
    • Of the 93.56 lakh who took only the first dose, so far 4,208 have got the infection.
    • That is about 0.04% of the total.
    • Among the 17.37 lakh who have taken the second shot, only 695 had been infected, again 0.04%.

    Challenges

    • “Given the scope of the pandemic, there’s a huge amount of virus in the world right now, meaning a huge opportunity for mutations to develop and spread.
    • That is going to be a challenge for the developers of vaccines.

  • Emergency use nod for Virafin

    About the drug

    • It is used in treating people with chronic hepatitis B and C. 
    • The Drug Controller General of India (DCGI) granted emergency use approval for pharma major Zydus Cadila’s antiviral drug ‘Virafin’, to treat moderate COVID-19 disease in adults.
    • When administered early on during COVID, Virafin will help patients recover faster and avoid much of the complications.
    • It significantly reduces viral load when given early on and can help in better disease management.

    Findings of the clinical trials

    • A single dose subcutaneous regimen of the antiviral Virafin [a pegylated interferon alpha-2b (PegIFN)] will make the treatment more convenient for the patients.
    • When administered early on during COVID, Virafin will help patients recover faster and avoid much of the complications.
    • In the phase-3 trials, the drug was able to achieve “better clinical improvement in the patients suffering from COVID-19”.
    • A “higher proportion (91.15%) of patients administered the drug were RT-PCR negative by day seven as it ensures faster viral clearance”.
    • The drug reduced the duration for supplemental oxygen to 56 hours from 84 hours in moderate COVID-19 patients.

    How the drug works

    • Type I interferons are the body’s first line of defence against many viral infections.
    • In old people, the ability to produce interferon alpha in response to viral infections gets reduced, which might be the reason for higher mortality.
    • The drug when administered early during the disease can replace this deficiency and help in the recovery process.